1. Disease severity, patient‐reported outcomes and skin hydration improve during balneotherapy with hydrocarbonate‐ and sulphur‐rich water of psoriasis. (17th September 2020) Authors: Darlenski, R.; Bogdanov, I.; Kacheva, M.; Zheleva, D.; Demerdjieva, Z.; Hristakieva, E.; Fluhr, J.W.; Tsankov, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 3(2021) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953). (October 2020) Authors: Do, K.T.; Frej, K.; Bhushan, K.; Pruitt-Thompson, S.; Zheleva, D.; Blake, D.; Chiao, J.; Shapiro, G.I. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapeutic potential of novel PLK1 inhibitor CYC140 in esophageal cancer and acute leukemia. (December 2016) Authors: Moureau, S.; Pohler, E.; Kroboth, K.; Saladino, C.; MacKay, C.; Hollick, J.; Zheleva, D.; Frame, S.; Blake, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗